NCT02502500View on ClinicalTrials.gov

Effect of AKB-6548 on the Pharmacokinetics of Celecoxib

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

Celecoxib

DRUG

AKB-6548

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY